Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# robots.txt for http://www.inbiomotion.com User-agent: * Sitemap: http://www.inbiomotion.com/sitemap.xml Disallow: /media/php/socialwall/get_stream.php Disallow: /about-us/board-of-directors-and-management Disallow: |
Title | Inbiomotion: Predicting bone metastasis | |
Description | Developing personalized adjuvant treatment strategies for early-stage breast cancer: Addressing a Inbiomotion is a Barcelona-based personalized medicine company incorporated in 2010 with the goal of developing biomarkers that predict bone metastasis to improve the quality of life of cancer |
Keywords | N/A |
WebSite | inbiomotion.com |
Host IP | 216.92.70.168 |
Location | United States |
Site | Rank |
US$299,661
Last updated: 2023-05-09 02:17:44
inbiomotion.com has Semrush global rank of 35,320,963. inbiomotion.com has an estimated worth of US$ 299,661, based on its estimated Ads revenue. inbiomotion.com receives approximately 34,577 unique visitors each day. Its web server is located in United States, with IP address 216.92.70.168. According to SiteAdvisor, inbiomotion.com is safe to visit. |
Purchase/Sale Value | US$299,661 |
Daily Ads Revenue | US$277 |
Monthly Ads Revenue | US$8,299 |
Yearly Ads Revenue | US$99,580 |
Daily Unique Visitors | 2,306 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
inbiomotion.com. | A | 900 | IP: 216.92.70.168 |
inbiomotion.com. | NS | 900 | NS Record: dns1.nominalia.com. |
inbiomotion.com. | NS | 900 | NS Record: dns2.nominalia.com. |
inbiomotion.com. | MX | 3600 | MX Record: 0 inbiomotion-com.mail.protection.outlook.com. |
inbiomotion.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
inbiomotion.com. | TXT | 3600 | TXT Record: MS=ms30334851 |
inbiomotion.com. | TXT | 900 | TXT Record: google-site-verification=1dQXWAXlNQ_RTBaNKSzR_oNF--NSHLerP-qoT4IYxBs |
Menu Developing personalized adjuvant treatment strategies for early-stage breast cancer: Addressing a clear unmet medical need Inbiomotion focuses on providing a unique companion diagnostic solution, to address an urgent and unmet medical need in the personalized adjuvant treatment of early-stage breast cancer. Founded in 2010 by Prof. Roger Gomis, Inbiomotion is a spin-off of IRB Barcelona and ICREA research institutions. Our unique diagnostic assay is based on a highly selective, single-gene biomarker, of the MAF gene. The MAF test has the potential to identify early-stage breast cancer patients who will benefit from bisphosphonate adjuvant treatment, with the aim to improve their overall and disease-free survival, while excluding patients who will not benefit or can be harmed. It can further predict, at an early stage, a patient’s risk of metastases relapse from primary tumors. News 20 December 2022 Inbiomotion appoints Ralf van den Berg as Chief Operating Officer Ralf van den |
HTTP/1.1 301 Moved Permanently Date: Sun, 31 Oct 2021 02:43:04 GMT Server: Apache Location: http://www.inbiomotion.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sun, 31 Oct 2021 02:43:04 GMT Server: Apache Set-Cookie: PHPSESSID=rdgkllcur8tg734fghiq1t9055; path=/ Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: private Pragma: no-cache Set-Cookie: lang=en; expires=Mon, 31-Oct-2022 02:43:04 GMT; Max-Age=31536000; path=/ Last-Modified: Tue, 28 Sep 2021 13:05:08 +0200 Content-Type: text/html; charset=UTF-8 |
Domain Name: INBIOMOTION.COM Registry Domain ID: 1683938403_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.nominalia.com Registrar URL: http://www.nominalia.com Updated Date: 2020-10-05T04:04:05Z Creation Date: 2011-10-25T10:49:11Z Registry Expiry Date: 2021-10-25T10:49:11Z Registrar: Nominalia Internet S.L. Registrar IANA ID: 76 Registrar Abuse Contact Email: abuse@nominalia.com Registrar Abuse Contact Phone: +39.05520021555 Domain Status: ok https://icann.org/epp#ok Name Server: DNS1.NOMINALIA.COM Name Server: DNS2.NOMINALIA.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T12:50:57Z <<< |